scholarly journals A Study of “Osteoporosis due to lack of Vitamin - D deficiency” through a small Survey in Kolkata, (West Bengal)

2021 ◽  
Vol 9 (4) ◽  
pp. 101-110
Author(s):  
S Rehan Ahmed ◽  
Keyword(s):  
Vitamin D ◽  
Bone Loss ◽  
Health Care Providers ◽  
Bone Health ◽  
Healthy Lifestyle ◽  
The Body ◽  
Care Providers ◽  
Long Term Effects ◽  
Resultant Increase

Bone loss and osteoporosis with the resultant increase in fracture risk should be major concerns for patients and health care providers. As the population ages, the long-term effects of osteoporosis including pain, loss of independence and institutionalized care will become more prevalent. Efforts to prevent bone loss and osteoporosis should start with proper education about a healthy lifestyle, including optimal calcium and vitamin D and exercise in adolescence. This education should continue throughout life, with emphasis during times of increased bone loss such as the menopause transition. This paper reviews the cornerstone of bone health; calcium and vitamin D. Although dietary sources of both nutrients are available, most people do not receive adequate amounts for proper bone health. In addition, the heightened awareness of damaging effects of sunlight has limited vitamin D synthesis from the skin. Fortunately, supplements are available that can supply the body with amounts necessary for bone health.

Does Photosensitivity Predict Photococarcinogenicity?

1999 ◽  
Vol 18 (3) ◽  
pp. 191-198 ◽  
Author(s):  
Abigail Jacobs ◽  
Javier Avalos ◽  
Paul Brown ◽  
Jonathan Wilkin
Keyword(s):  
Health Care Providers ◽  
Drug Evaluation ◽  
Safety Evaluation ◽  
Care Providers ◽  
Simulated Sunlight ◽  
Long Term Effects ◽  
Short Term ◽  
Drug Products ◽  
Exposed Skin

Assessment of short-term and long-term effects of light (pho—totesting) is part of the safety evaluation of drugs. Results are incorporated into drug package inserts to advise patients and health care providers about the use of drug products on sun—exposed skin. We undertook an exhaustive literature search and a search of archived studies at the Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA), in order to evaluate the potential of short—term photoassays to predict long—term effects of drugs used in sunlight (280–700 nm). The correlation between the findings from the photococarcinogenicity assays in mice that used exposure to simulated sunlight and those from photogenotoxicity and photosensitivity studies was examined. Results indicated that photosensitivity and photogenotoxicity assays did not necessarily predict effects in photococarcinogenicity studies in mice. Effects of drugs on skin that are not due to photoactivation of drug can be important factors in enhancement of UV—induced skin carcinogenesis.

Pain in the Neonate: Focus on Nonpharmacologic Interventions

2014 ◽  
Vol 33 (6) ◽  
pp. 336-340 ◽  
Author(s):  
Brandy Zeller ◽  
Jeanne Giebe
Keyword(s):  
Health Care Providers ◽  
Preterm Neonates ◽  
Care Providers ◽  
Long Term Effects ◽  
Neonatal Pain ◽  
American Academy Of Pediatrics ◽  
Vulnerable Patients ◽  
Assessment And Treatment ◽  
Parent Groups

ABSTRACTThe assessment and treatment of pain in the neonate, especially preterm neonates, has been a challenge in the NICU for many years. Nurses caring for these vulnerable patients are in a key position to not only recognize when the neonate is experiencing pain but to also work collaboratively with other health care providers in determining the best method to treat and help prevent pain associated with procedures and routine caregiving activities. The American Academy of Pediatrics along with parent groups has recognized the importance of pain-prevention programs in treating pain in the neonate. Nurses, by anticipating and reducing both painful procedures and bedside interruptions, along with innovative nonpharmacologic interventions, can dramatically decrease the neonate’s exposure to pain and the potential for long-term effects. An overview of nonpharmacologic interventions in the treatment of neonatal pain is provided for NICU nurses to help them effectively reduce their patient’s pain and discomfort.

scholarly journals Maternal vitamin D deficiency and developmental origins of health and disease (DOHaD)

2019 ◽  
Vol 241 (2) ◽  
pp. R65-R80 ◽  
Author(s):  
Folami Y Ideraabdullah ◽  
Anthony M Belenchia ◽  
Cheryl S Rosenfeld ◽  
Seth W Kullman ◽  
Megan Knuth ◽  
...  
Keyword(s):  
Vitamin D ◽  
Vitamin D Deficiency ◽  
Later Life ◽  
The Body ◽  
Fetal Life ◽  
Developmental Origins ◽  
Long Term Effects ◽  
Cardiometabolic Disorders ◽  
Health And Disease

Vitamin D is an essential nutrient that is metabolized in the body to generate an active metabolite (1,25(OH)2D) with hormone-like activity and highly diverse roles in cellular function. Vitamin D deficiency (VDD) is a prevalent but easily preventable nutritional disturbance. Emerging evidence demonstrates the importance of sufficient vitamin D concentrations during fetal life with deficiencies leading to long-term effects into adulthood. Here, we provide a detailed review and perspective of evidence for the role of maternal VDD in offspring long-term health, particularly as it relates to developmental origins of health and disease (DOHaD). We focus on the roles in neurobehavioral and cardiometabolic disorders in humans and highlight recent findings from zebrafish and rodent models that probe potential mechanisms linking early life VDD to later life health outcomes. Moreover, we explore evidence implicating epigenetic mechanisms as a mediator of this link. Gaps in our current understanding of how maternal VDD might result in deleterious offspring outcomes later in life are also addressed.

scholarly journals ASSESSMENT OF KNOWLEDGE, ATTITUDE AND PRACTICES REGARDING VITAMIN D AMONG STUDENTS OF SAIDU MEDICAL COLLEGE, SWAT

2017 ◽  
Vol 7 (1) ◽  
pp. 1-4 ◽  
Author(s):  
Fazale Haq ◽  
Rukhsana Khan ◽  
Zille Huma Mustehsan
Keyword(s):  
Vitamin D ◽  
Vitamin D Deficiency ◽  
Health Care Providers ◽  
Public Health Problem ◽  
Sunlight Exposure ◽  
The Body ◽  
Care Providers ◽  
Dietary Practices ◽  
Medical College ◽  
Vitamin D Levels

Background: Vitamin D is also known as the “Vitamin of Sun”. More than one billion people are suffering from Vitamin D deficiency globally; it is an epidemic and a very serious global public health problem. In South Asia, Vitamin D deficiency is quite prevalent. Many recent studies have shown that vitamin D helps in preventing cancer, cardiovascular diseases and diabetes.Objectives: To assess the knowledge, attitude, dietary and sunshine practices regarding Vitamin D among students of Saidu Medical College, Swat.Methods: A cross sectional study was carried out among 106 students of Saidu Medical College, Swat. Self-administered questionnaire was distributed to all students and data was analyzed on SPSS 20.Results: Majority of the students 72% had good knowledge of Vitamin D and its synthesis in the body. 91% of the students were aware of the source of Vitamin D and 87.5% knew about sources of vitamin D. However, the  attitude of students towards sunlight exposure was poor as 65.2% students disliked being in the sun, 62.5%  thought that sunlight exposure was harmful for skin, and 65.4% of the students thought that their Vitamin D  levels were sufficient without getting their laboratory tests done.59.6% students used sunscreen in summer.Conclusion: The student's knowledge about Vitamin D was good but their attitude towards sun exposure and dietary practices did not match their knowledge. Medical students, being the future physicians and health care providers, must possess current knowledge about Vitamin D and should also look after their own health and dietary practices.

Parents’ Experience When Present During a Child’s Resuscitation: An Integrative Review

2019 ◽  
Vol 41 (9) ◽  
pp. 1282-1305 ◽  
Author(s):  
Stephanie A. Stewart
Keyword(s):  
Health Care Providers ◽  
Parent Stress ◽  
Stress And Coping ◽  
Integrative Review ◽  
Care Providers ◽  
Inclusion Criteria ◽  
Long Term Effects ◽  
And Coping ◽  
Parent Presence

Understanding perceptions of parents is necessary to meet parents’ needs during a child’s resuscitation. Parent presence at pediatric resuscitations has been slow to become consistent practice in all hospital settings and remains controversial. The purpose of this integrative review was to synthesize research on parents’ experience while present during a child’s resuscitation to improve understanding for health care providers and to facilitate application in practice. Nine studies met inclusion criteria, identifying four major themes. Parents experienced conflicting emotions, articulated a need for communication and support, reported that being physically present was comforting, and described their reactions to the experience. The available research on parents’ experience during presence at their child’s resuscitation offers a foundation for further detailed study. Further study is needed about parents’ perspective of support needed while present during a child’s resuscitation, as well as about any long-term effects of presence on parent stress and coping.

scholarly journals Cancer Treatment–Induced Bone Loss (CTIBL): State of the Art and Proper Management in Breast Cancer Patients on Endocrine Therapy

2021 ◽  
Vol 22 (5) ◽  
Author(s):  
Anna Diana ◽  
Francesca Carlino ◽  
Emilio Francesco Giunta ◽  
Elisena Franzese ◽  
Luigi Pio Guerrera ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Bone Loss ◽  
Cancer Treatment ◽  
Endocrine Therapy ◽  
Aromatase Inhibitors ◽  
Bone Health ◽  
Optimal Time ◽  
Breast Cancer Patients ◽  
Antiresorptive Agents

Opinion statementAbout 70–80% of early breast cancer (BC) patients receive adjuvant endocrine therapy (ET) for at least 5 years. ET includes in the majority of cases the use of aromatase inhibitors, as upfront or switch strategy, that lead to impaired bone health. Given the high incidence and also the high prevalence of BC, cancer treatment–induced bone loss (CTIBL) represents the most common long-term adverse event experimented by patients with hormone receptor positive tumours. CTIBL is responsible for osteoporosis occurrence and, as a consequence, fragility fractures that may negatively affect quality of life and survival expectancy. As recommended by main international guidelines, BC women on aromatase inhibitors should be carefully assessed for their fracture risk at baseline and periodically reassessed during adjuvant ET in order to early detect significant worsening in terms of bone health. Antiresorptive agents, together with adequate intake of calcium and vitamin D, should be administered in BC patients during all course of ET, especially in those at high risk of osteoporotic fractures, as calculated by tools available for clinicians. Bisphosphonates, such as zoledronate or pamidronate, and anti-RANKL antibody, denosumab, are the two classes of antiresorptive drugs used in clinical practice with similar efficacy in preventing bone loss induced by aromatase inhibitor therapy. The choice between them, in the absence of direct comparison, should be based on patients’ preference and compliance; the different safety profile is mainly related to the route of administration, although both types of drugs are manageable with due care, since most of the adverse events are predictable and preventable. Despite advances in management of CTIBL, several issues such as the optimal time of starting antiresorptive agents and the duration of treatment remain unanswered. Future clinical trials as well as increased awareness of bone health are needed to improve prevention, assessment and treatment of CTIBL in these long-term survivor patients.

Multimorbidity, Consumer-Directed Care, and Drug-Related Harm

2021 ◽  
Vol 36 (3) ◽  
pp. 125-126
Author(s):  
Chris Alderman
Keyword(s):  
Health Care Providers ◽  
Developed Countries ◽  
Care Practice ◽  
Care Providers ◽  
Term Care ◽  
Societal Challenges ◽  
Psychiatric Conditions ◽  
New Treatments ◽  
Related Harm

People from developed countries around the world now routinely live into their 80s and beyond, and this is associated with a range of medical and societal challenges that must be addressed. It is relatively rare to encounter older people who are not affected by one or more chronic diseases, including conditions such as osteoarthritis, gastroesophageal reflux disease (GERD), hypertension, and depression. The concurrence of a number of medical and/or psychiatric conditions in the same patient has come to be referred to as multimorbidity, and it is a particularly familiar phenomenon observed by health care providers in settings such as the Emergency Department (ED), primary care practice, and long-term care facilities. Given that life expectancy continues to increase, and that there is considerable further investment in research for the development of new treatments, which will achieve adoption and be promoted to consumers, it is clear that multimorbidity is likely to be a driver for problems arising from medications that are vigorously promoted to consumers.

Depression: A Long-Term Illness

1994 ◽  
Vol 165 (S26) ◽  
pp. 9-15 ◽  
Author(s):  
Martin B. Keller
Keyword(s):  
Health Care ◽  
Health Care Providers ◽  
Maintenance Treatment ◽  
Depressive Disorders ◽  
Care Providers ◽  
Serious Illness ◽  
Antidepressant Treatments ◽  
Continued Education ◽  
Low Levels

The realisation that major depression is often both chronic and recurrent has slowly begun to change the way that depression is diagnosed and treated. In particular, the need for continuation and maintenance treatment is an issue that now deserves increased attention, especially with the availability of new classes of antidepressant treatments, which have excellent efficacy and more favourable side-effect profiles. Although the serious consequences of depressive disorders clearly indicate the need for effective and prompt intervention on the part of clinicians, the results of several studies indicate that patients with depression consistently receive no or low levels of antidepressant therapy. It is hoped that, through continued education of health care providers and patients about the consequences of depression, the issue of undertreatment of this serious illness will be resolved.

scholarly journals The Issue of Aversion in Lifestyle Treatments

2016 ◽  
Vol 11 (2) ◽  
pp. 119-121 ◽  
Author(s):  
Katherine R. Arlinghaus ◽  
John P. Foreyt ◽  
Craig A. Johnston
Keyword(s):  
Physical Activity ◽  
Health Care ◽  
Health Care Providers ◽  
Bone Health ◽  
Self Efficacy ◽  
Vigorous Physical Activity ◽  
Care Providers ◽  
Behavior Adjustment

Increasing evidence suggests that vigorous physical activity (PA) is more beneficial than moderate PA for reducing adiposity and improving bone health in youth. However, beginning a vigorous PA program is not an easy behavior adjustment and the change is likely to be aversive for some individuals. In order to benefit from vigorous PA, health care providers need to help individuals increase self-efficacy.

Sign in / Sign up

Export Citation Format

Share Document